Depends really on what valuation basis you are using - at revenue model, maybe. The fact atm, unfortunately, is there is cashflow pressure to pay off the loan. If you look at the P&L, the group still not making profit. There is no point of doubling your revenue if you are spending more anyway to generate it. So at EBIT and Revenue valuation basis, the current MC is about right.
- Forums
- ASX - By Stock
- JAT
- Ann: SPP Results
Ann: SPP Results, page-33
-
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add JAT (ASX) to my watchlist
(20min delay)
|
|||||
Last
69.8¢ |
Change
-0.003(0.36%) |
Mkt cap ! $58.07M |
Open | High | Low | Value | Volume |
68.0¢ | 69.8¢ | 65.5¢ | $22.13K | 32.39K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2765 | 69.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
70.0¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2765 | 0.695 |
2 | 10013 | 0.680 |
1 | 9187 | 0.675 |
1 | 20000 | 0.655 |
1 | 3846 | 0.650 |
Price($) | Vol. | No. |
---|---|---|
0.700 | 5000 | 1 |
0.725 | 16667 | 1 |
0.750 | 134409 | 2 |
0.760 | 58122 | 2 |
0.770 | 59818 | 2 |
Last trade - 15.16pm 21/10/2024 (20 minute delay) ? |
Featured News
JAT (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online